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Coffee and black tea are among the most consumed beverages worldwide. While their potential 
role in lung cancer occurrence has been investigated in several studies, results have been 
inconclusive. We investigated the associations between intake of coffee and black tea with lung 
cancer in a population-based case-control study in Montreal, Canada. 
  
Methods 
These analyses included 1,130 cases and 1,483 controls. Adjusted odds ratios (OR) were 
estimated between four metrics of coffee and black tea consumption (frequency, average 




The adjusted ORs (95% confidence intervals) for lung cancer comparing daily to never 
consumers were 0.73 (0.49-1.10) for coffee and 1.05 (0.85-1.31) for black tea. Analyses of other 
metrics did not reveal any clear patterns of increasing or decreasing risk with increasing amounts 
or duration of consumption. There was no strong evidence of OR modification by sex or smoking 




Our results do not provide strong support for associations between consumption of coffee and 
black tea and lung cancer. 
 
List of abbreviations: OR (odds ratio), CI (confidence interval), CSI (comprehensive smoking 
indicator) 
  







Coffee and tea, which are consumed worldwide by billions of individuals, may contribute 
to lung cancer risk. Both beverages are composed of hundreds of chemicals, some of which may 
reduce risk while others may increase it. For instance, catechins, found in tea, and chlorogenic 
acid, present in coffee, are antioxidants that could reduce lung cancer risk (1-4). Caffeine, present 
in both coffee and tea, could increase risk via activation of proteins involved in various 
regulatory signal transduction pathways (5). 
In a systematic review of the literature published through 2006, the available evidence on 
the associations between consumption of coffee and tea and lung cancer was judged to be limited 
and inconclusive (6). In two subsequently published meta-analyses (7, 8), the evidence was 
consistent with no association between black tea consumption and lung cancer, though in one of 
these, statistically significant heterogeneity between studies was reported (7). In subsequently 
published meta-analyses (8-11) and individual studies (12, 13) of coffee intake, positive 
associations were reported in all but one individual study (11); statistically significant 
heterogeneity between studies was reported in two of the meta-analyses (9, 10).  
Residual confounding by smoking may have affected the results in some studies of both 
coffee and black tea. For instance, in two of the meta-analyses that reported positive associations 
with coffee consumption, inverse associations were suggested among never smokers (9, 10). 
Also, only a few studies (14-17) have adjusted for occupational exposure to lung carcinogens, 
one of the most important lung cancer risk factors after smoking (18). Furthermore, lifetime 
duration of consumption of these beverages might be an important aspect in the association with 
lung cancer risk, but to our knowledge only one study has examined duration (16).  
In the context of a large population-based case-control study of lung cancer carried out in 
Montreal, Canada, we examined the association between coffee and black tea consumption and 
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lung cancer risk overall, by sex and smoking level, as well as separately according to histological 
subtype. 
  
Material and methods 
Study population 
The design of the study has been described previously (19). Briefly, participants were 
recruited from 1996 to 2001 and included Canadian citizens aged 35 to 75 years who resided in 
the greater Montreal area. Incident lung cancer cases were identified in the 18 major hospitals 
serving the study region, and controls were selected from the Quebec voter registration list and 
frequency matched to the cases by 5-year age group and sex. The response rate was 85% among 
cases and 69% among controls. The current analysis was limited to participants with complete 
information on their consumption of either coffee or tea, and on their smoking habits (n=1,111 
cases and 1,469 controls in the analysis of tea, and 1,009 cases and 1,434 controls in the analysis 
of coffee). Written informed consent was obtained from participants, and the study was approved 
by the Institutional Review Boards of participating universities and hospitals. 
 
Data collection 
Study participants or their proxies (for 389 cases and 103 controls) participated in a face-
to-face interview that was divided into two parts. The first part was a structured section during 
which data on socio-demographic characteristics (including ethnic group and highest level of 
schooling) and lifestyle (including coffee and tea intake, alcohol intake, other dietary factors, 
smoking, and physical activities) were collected. In the second part, a detailed description of 
lifetime occupational history was collected (19). Participants’ occupational histories were 
subsequently assessed by expert chemists and industrial hygienists to determine lifetime 
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occupational exposure to a list of nearly 300 agents (20-23). Family income was represented by 
the median family income level for the census tract the participant lived in at the time of 
interview. 
For tea and coffee consumption, participants were first asked if they drank the beverage at 
least once a week and if yes, they were then asked if they drank it nearly every day. For 
participants who reported drinking the beverage nearly every day, further questions were asked 
that assessed the age at which they started and stopped consumption, as was the average daily 
amount consumed (in cups) during the time that they were consumers. The specific type of tea 
consumed was not assessed, however, in the birth cohort of our participants (most born around 
1920-1950), lifetime tea consumption was predominantly black tea. Black tea has historically 
been the dominant type consumed in North America (24); in Canada, significant green tea 
importation began only in the late 1990s (reaching 17% of total tea imported in 2009 (25)). 
Similarly, our questionnaire did not differentiate between caffeinated and decaffeinated coffee; 
however, only around 8% of coffee consumed in Canada in 2010 was decaffeinated (26) and this 
proportion was likely much lower in the past. Thus, coffee consumption in our study population 
likely represents primarily caffeinated consumption. 
 
Study variables 
Four metrics were used to summarize lifetime coffee and black tea consumption 
including: 1) frequency of consumption; 2) average daily amount; 3) duration of consumption 
and; 4) cumulative amount.  For frequency of consumption, participants were categorized as 
‘never’ consumers if they reported not drinking coffee/black tea at least once per week during 
their life; ‘weekly, not daily’ consumers if they reported drinking coffee/black tea at least once 
per week but not nearly every day; and ‘daily’ consumers if they reported drinking coffee/black 
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tea nearly every day. Among ‘daily’ consumers, categorical variables of average daily amount of 
consumption, duration of consumption, and cumulative consumption, which incorporated 
measures of both daily amount and duration of consumption, were defined. Duration of 
consumption was calculated by subtracting the age at which participants started consuming the 
beverage from the age at which they stopped. To minimize the risk of reverse-causality bias, 
consumption during the two years preceding the diagnosis date for cases or the interview date for 
controls were not included in the calculation of duration of consumption.  
Data on consumption of wine was collected in a similar manner to that of coffee and black 
tea intake, and represented by a categorical variable. Lifetime history of cigarette smoking was 
represented by the comprehensive smoking index (CSI) (27), which is a continuous variable that 
incorporates information on smoking status, duration of smoking, time since the cessation of 
smoking, and average daily intensity of smoking. Exposure to seven known occupational lung 
carcinogens (asbestos, crystalline silica, chromium VI compound, nickel compounds, 
benzo(a)pyrene, cadmium compounds and diesel engine emissions) was represented by a 
categorical variable defining participants as never exposed, exposed to at least one of the seven 
carcinogens but only at non-substantial levels or exposed to at least one of the seven carcinogens 
at substantial levels. For a given occupational carcinogen, substantial exposure was defined as 
exposure to a medium or high level concentration for at least 5 years and for at least 2 hours per 
week, while non-substantial exposure was defined as exposure to a low concentration and/or 
shorter duration of exposure. Categorical variables were used to represent ethnic group and 






The distribution of study variables was examined by case/control status. To assess the 
association between each metric of coffee or black tea consumption and lung cancer, odds ratios 
(OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression. 
Multivariable models included the frequency matching variables (age and sex) and covariates that 
were identified a priori based on their known association with lung cancer: ethnicity, family 
income (from median of census tract), years of education, smoking (CSI), and occupational 
exposure to lung carcinogens. Each model was also adjusted for respondent status (self/proxy). In 
addition, we considered potential confounding by exposure to other dietary variables (i.e. fruits 
and vegetables, wine, beer, and spirits), by entering each variable individually and retaining the 
variable if the OR changed by at least 10%. Only the variable for wine intake was retained and in 
9 cases and 2 controls with missing values, the modal value among controls (never drinker) was 
used 
Modification of the ORs for coffee or black tea consumption and lung cancer risk by sex 
or by smoking level was evaluated by including in the models product terms for the consumption 
metric and the potential effect modifier. The p-value for multiplicative interaction was based on 
the likelihood ratio test comparing the models with and without the product terms. Smoking level 
was categorized as never, light, and heavy, where light smoking and heavy smoking were defined 
based on dichotomizing at the median CSI value (1.928) among all ever-smokers in the study 
population. Because there were few cases in the never-smoking category (47 cases), never-
smoking and light-smoking were combined into one category. Within each level of smoking, 
models were still adjusted for the continuous CSI variable.  
We examined associations with histological subtype by conducting separate analyses 
based on the cases of a specified histological subtype and all controls. In sensitivity analyses, 
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analyses were restricted to self-respondents to assess the potential for information bias due to 
potentially poorer quality of recall by proxy respondents relative to self-respondents. We also 
conducted analyses where consumption of coffee or black tea during the 20 years prior to 
diagnosis or interview was not included in the exposure definition in order to examine 
associations with exposures restricted to the operational induction period of lung cancer. 
 
Results 
The majority of participants were male and over 65 years old (table I). Adenocarcinoma 
and squamous cell carcinoma were the most common histological subtypes of lung cancer. 
Compared to controls, cases were more likely to be represented by a proxy respondent during the 
interview, to be French Canadian, to have had fewer years of schooling, to have a lower family 
income, to be an ever-smoker, to have consumed less wine, and to have been exposed to the 
selected occupational carcinogens. 
For black tea consumption, there was no strong pattern of association between frequency 
of consumption and lung cancer risk, nor for the quantitative metrics of daily consumption (table 
II). For daily coffee consumption an OR estimate of 0.73 was observed in the fully adjusted 
models, but the confidence limits did not exclude 1.0, while for weekly, but not daily coffee 
consumption, the OR was lower and statistically significant (table III). None of the quantitative 
metrics of daily coffee consumption indicated a monotonic dose-response pattern. However, 
compared to never drinking coffee, the lowest categories of amount of daily coffee consumption 
and lowest category of cumulative consumption indicated statistically significant lower risks of 
lung cancer, but OR estimates were virtually null for the highest intake categories for these 
variables. Differences observed between the age-/sex-adjusted versus fully-adjusted OR estimates 
were mainly due to confounding by smoking (results not shown). Similar results were observed 
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for all metrics of coffee and black tea consumption when excluding the last 20 years of 
consumption from the exposure definition, and by restricting the analyses to self-respondents 
(results not shown). When examining the joint effects of ‘never’ vs. ‘ever’ consumption of tea 
and coffee intake, the results were too imprecise to allow discrimination between the hypotheses 
of presence or absence of multiplicative interaction (results not shown). 
Associations between black tea and coffee consumption and lung cancer did not 
statistically significantly differ by sex or by smoking level (all p-values for multiplicative 
interaction were greater than 0.05) (appendix tables A.I and A.II). The results according to 
histological type were very imprecise (table IV), with four of the tested associations being 
statistically significant (i.e, for >50 years of black tea consumption and adenocarcinoma 
(OR=1.60), for >2 cups/day of black tea for ≤ 40 years and squamous cell carcinoma (OR=2.18), 
and for weekly but not daily consumption of coffee with both squamous cell carcinoma and small 
cell carcinoma (ORs=0.33 and 0.10, respectively). 
 
Discussion 
In this large population-based case-control study, we did not observe evidence for an 
association between black tea consumption, defined according to frequency, amount, duration, 
and cumulative consumption, and lung cancer overall, nor subgroups defined by sex or level of 
smoking. For coffee consumption, there was evidence of a lower risk of lung cancer among 
weekly but not daily consumers compared to never consumers. Similarly, there was some 
evidence that lower coffee intakes defined by average daily amounts and cumulative 
consumption may be associated with lower risks. The associations between coffee intake and 
lung cancer did not vary significantly by sex or smoking level.  While some statistically 
significant associations with certain metrics of coffee or black tea intake were observed for 
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different histological types, in general the estimated ORs did not vary appreciably across 
histological subtypes of lung cancer. 
In previous research, five cohort studies (13, 28-31) and 14 case-control studies (14, 15, 
17, 32-42) have examined lung cancer risk in relation to black tea consumption (15, 30, 31, 40-
42) or tea consumption in countries where black tea was the predominant type consumed (13, 14, 
17, 28, 29, 32-39). Findings have been inconsistent with studies having reported positive (14, 17, 
31, 37-39, 42), inverse (29, 31, 32, 34-36, 41, 42) and null (13, 15, 28, 30, 33, 40-42) associations 
for increasing intakes in populations of men only, women only and/or men and women together. 
Of those results that were statistically significant, three (37-39) suggested a positive association 
and six (29, 32, 35, 36, 41, 42) suggested an inverse association.  
For coffee intake, eight cohort studies (12, 13, 31, 43-47) and 14 case-control studies (14-
17, 33-39, 42, 48, 49) have previously reported associations with lung cancer. Out of 30 relative 
risks for increasing coffee intakes reported for men only, women only and/or both men and 
women across these 22 studies, 17 were in the positive direction (12-15, 31, 33, 34, 38, 39, 44-
49), which was statistically significant in eight (12-15, 38, 45, 46, 48). Among the other results, 
the majority were near the null value, with only two having reported relative risk estimates of 0.5 
or less (17, 48), which were not statistically significant.  
Our results for black tea consumption do not provide strong evidence of an association 
with lung cancer risk. Tea has been hypothesized to reduce lung cancer risk because of its high 
concentration of catechins, an antioxidant (3). However, the principal catechins found in black 
tea are theaflavin and thearubigen, which are oxidized forms of catechins and less bioavailable 
(4). Thus, our findings, as well as that of others, may reflect the fact that the antioxidative 
properties of black tea are relatively weak. It is also possible that consumption habits such as 
beverage size, brewing time, quantity of black tea in a cup or the use of additives resulted in 
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antioxidant concentrations that were too small for an effect on lung cancer risk. We were unable 
to examine these factors, as they were not measured. 
For coffee consumption and lung cancer, we observed a statistically significantly inverse 
association with weekly consumption, but not with daily consumption. Our findings for average 
daily amount of coffee consumed and cumulative consumption were consistent with this lower 
relative risk at lower intakes, which then shifts towards the null at higher intakes. Coffee is a 
complex substance composed of hundreds of chemicals including antioxidants (1, 2), which 
could prevent cancer, as well as caffeine which has been shown to promote lung cancer 
proliferation (5) and inhibit the effects of antioxidants (50). Our observation of inverse 
associations only with lower consumption (i.e., presumably lower caffeine intake compared to 
daily/higher consumption) may reflect the possibility that at higher amounts of coffee 
consumption, any positive effect of antioxidants may be counterbalanced by a carcinogenic effect 
of caffeine in coffee. In five previous studies that specifically assessed decaffeinated coffee (12, 
13, 15, 33, 39), strong inverse associations with lung cancer were reported in three (15, 33, 39), 
supporting the notion that coffee contains potentially cancer preventive properties. Furthermore, 
in studies of caffeinated coffee where the reference category included low consumers (15, 45, 46, 
48), rather than an ‘unexposed’ group of non-drinkers, the observed statistically significant 
positive associations support the notion that increasing caffeine intakes might increase risk, and 
thus possibly mask any protective effects of other components of coffee. Interestingly, one study 
(49) reported a similar pattern of association, with a statistically significant lower risk at the 
lowest level of consumption vs. non-drinkers but a non-significant higher risk at the highest 
consumption. On the other hand, the non-monotonic relation with coffee intake suggested in our 
study may reflect chance.  
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A fairly unique aspect of our study was our ability to examine risk as a function of 
duration of intake. Only one other study analyzed duration of coffee consumption and, similar to 
us, observed no statistically significant association with lung cancer (16). Our findings for 
different histological types were consistent with the relatively few studies of black tea (15, 36, 
42) and coffee consumption (12, 15-17, 36, 42, 48) that reported no significant differences in the 
strength or direction of the associations for different histological subtypes of lung cancer. 
 Cases and controls were identified from the same study base, the identification of 
participants was independent of coffee or black tea, and the participation rates were quite high, 
thus minimizing the potential for selection bias. With 1,130 cases and 1,483 controls overall, we 
were able to explore differences by histological subtype and potential effect modification by sex 
and smoking. Nonetheless, these results were characterized by a high degree of statistical 
imprecision. Also, detailed information on frequency and duration of consumption was not 
collected for ‘weekly, not daily’ consumers thus limiting the number of participants included in 
analyses of metrics based on these variables.  
A major strength of our study was the detailed assessment of smoking history, the most 
important potential confounder in our study. In particular, we adjusted for the CSI, a metric that 
was previously developed and validated by our team (27) and that incorporates, in an optimal 
manner, the key lung cancer-relevant aspects of cigarette-smoking history, including total 
duration of cigarette smoking, the average smoking intensity, and time since cessation. 
Furthermore, the detailed assessment of occupational history along with expert assessment of 
lung carcinogen exposure allowed for high quality control for potential confounding by the most 
important occupational lung carcinogens. Nonetheless, the weak inverse association we observed 
for weekly coffee intake may reflect confounding by unobserved confounding factors and/or residual 
confounding due to incomplete control for observed confounding factors. Prospective studies with 
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multiple assessments of exposures and covariates may reduce residual confounding due to error in 
measurement of observed confounders, while the effect of unobserved confounders can be addressed 
in instrumental variable-based designs (51, 52). 
Our questionnaire assessed coffee and tea over the lifetime, in contrast to traditional food 
frequency questionnaires, which generally provides a measure of usual intake of various foods 
and beverages over a relatively recent period of time (such as past month or past year) (53). Thus, 
our assessment allowed us to have an estimate of lifetime intake which is particularly important 
in a study of cancer etiology as lifetime intake is more likely to better capture periods of etiologic 
relevance than current or very recent intake. Nonetheless, recall over a long period may 
contribute to misclassification of exposure, though studies have shown that intake of coffee and 
other dietary factors can be reliably and validly reported (54, 55), especially when interviewer-
administered (56), as was the case in our study. Another potential source of non-differential 
misclassification of exposure is the absence of information on factors that may affect the 
concentration of relevant chemical components in the beverage (e.g. brewing time). The use of 
proxy respondents for some participants also may have resulted in exposure misclassification 
because of possible lower quality data, although our findings did not appreciably differ upon 
restricting the analysis to self-respondents. 
In summary, our results do not provide strong support for an association between 
consumption of coffee or black tea and lung cancer. For coffee, our results are suggestive that 
low consumption may decrease the risk of lung cancer. Research that includes more detailed 
information on these beverages, including specific components of these beverages such as 
caffeine, may offer further insight.
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Table I. Characteristics of the study participants 




Age   
 <45 years 37 (3.3) 52 (3.5) 
 45 - <55 years 164 (14.5) 202 (13.6) 
 55 - <65 years 381 (33.7) 442 (29.8) 
 65 - <75 years 511 (45.2) 745 (50.3) 
 ≥75 years 37 (3.3) 42 (2.8) 
Sex    
 Male 677 (59.9) 878 (59.2) 
 Female 453 (40.1) 605 (40.8) 
Respondent status   
 Self 741 (65.6) 1380 (93.1) 
 Proxy 389 (34.4) 103 (6.9) 
Ethnic group   
  French Canadian 876 (77.5) 979 (66.0) 
 English Canadian 74 (6.6) 82 (5.5) 
 Other 180 (15.9) 422 (28.5) 
Years of schooling   
 <7 285 (25.1) 312 (21.0) 
 7 - <12 553 (48.9) 563 (38.0) 
 ≥12 292 (25.8) 608 (41.0) 
Median census tract family income   
 Low 500 (44.3) 491 (33.1) 
 Middle 369 (32.7) 503 (33.9) 
 High 261 (23.1) 489 (33.0) 
Cigarette smoking    
 Never 47 (4.2) 460 (31.0) 
 Ex-smoker 644 (57.0) 690 (46.5) 
 Current smoker 439 (38.8) 333 (22.5) 
 
Average amount, cigarettes/year 
(median (IQR))1 1175 (773) 775 (838) 
 
Time since cessation, years (median 
(IQR))2 1.2 (10.2) 17.7 (16.6) 
 
Smoking duration, years (median 
(IQR))1 43.0 (14.4) 33.2 (21.1) 
Wine consumption   
 Never 739 (65.4) 665 (44.8) 
 Weekly, not daily 225 (19.9) 545 (36.8) 
 Daily 166 (14.7) 273 (18.4) 
Exposures to occupational carcinogens3   
 Never exposed 652 (57.7) 935 (63.0) 
 Non-substantially exposed 303 (26.8) 372 (25.1) 
 Substantially exposed 175 (15.5) 176 (11.9) 
Histological subtype   
 Squamous cell carcinoma 328 (29.0)  
 Adenocarcinoma 443 (39.2)  
 Small cell carcinoma 187 (16.6)  
1. Includes ex-smokers and current smokers only 
2. Includes ex-smokers only 
3. Exposure to asbestos, crystalline silica, chromium VI compound, nickel compounds, benzo(a)pyrene, cadmium compounds or diesel engine 
emissions 
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Age and sex adjusted 
OR (95% CI) 
Fully adjusted 
OR (95% CI)2 
Frequency of consumption     
 Never3 551 604 1.00 (ref) 1.00 (ref) 
 Weekly, not daily4 127 281 0.49 (0.39 - 0.62) 0.78 (0.58 – 1.05) 
 Daily 433 584 0.83 (0.70 - 0.98) 1.05 (0.85 – 1.31) 
Average daily amount of consumption5     
 Never3 551 604 1.00 (ref) 1.00 (ref) 
 ≤ 1 cup/day 128 238 0.60 (0.47-0.76) 0.95 (0.70-1.28) 
 >1 to 2 cups/day 162 219 0.84 (0.66-1.06) 1.06 (0.79-1.42) 
 >2 cups/day 143 127 1.27 (0.97-0.99) 1.25 (0.90-1.75) 
Duration of consumption5     
 Never3 551 604 1.00 (ref) 1.00 (ref) 
 < 20 years 52 61 0.89 (0.60 - 1.32) 1.41 (0.87 – 2.29) 
 ≥ 20 to < 30 years 39 55 0.67 (0.43 - 1.04) 0.97 (0.57 – 1.64) 
 ≥ 30 to < 40 years 80 106 0.76 (0.56 - 1.05) 0.98 (0.66 – 1.45) 
 ≥ 40 to < 50 years 141 203 0.81 (0.63 - 1.04) 0.94 (0.69 – 1.28) 
 ≥ 50 years 121 159 0.99 (0.74 - 1.31) 1.24 (0.87 – 1.78) 
Cumulative consumption5     
 Never3 551 604 1.00 (ref) 1.00 (ref) 
 ≤ 40 years, ≤ 2 cups/day 118 187 0.63 (0.49-0.83) 0.97 (0.70-1.34) 
 ≤ 40 years, > 2 cups/day 53 39 1.37 (0.89-2.12) 1.49 (0.88-2.52) 
 > 40 years, ≤ 2 cups/day 172 270 0.77 (0.61-0.98) 1.03 (0.77-1.38) 
 > 40 years, > 2 cups/day 90 88 1.23 (0.89-1.27) 1.14 (0.76-1.71) 
1. Only includes participants with complete information on their black tea consumption 
2. Adjusted for age, sex, respondent status, smoking (CSI), wine intake (never; weekly, not daily; daily), ethnicity (French Canadian; English 
Canadian; other), median census tract income (low; medium; high), years of education (<7; 7-<12; ≥12) and occupational exposure to 
carcinogens (Never; non-substantial; substantial) 
3. Participants were categorized as never consumers if they reported never consuming black tea at least once per week  
4: Participants were categorized as “weekly, not daily” consumers if they reported consuming black tea at least once per week but not nearly 
every day 
5. “Weekly, not daily” consumers not included
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Age and sex adjusted 
OR (95% CI) 
Fully adjusted  
OR (95% CI)2 
Frequency of consumption     
 Never3 89 88 1.00 (ref) 1.00 (ref) 
 Weekly, not daily4 32 108 0.29 (0.18 - 0.48) 0.29 (0.16 – 0.55) 
 Daily 888 1238 0.71 (0.52 - 0.97) 0.74 (0.49 – 1.10) 
Average daily amount of 
consumption5 
    
 Never3 89 88 1.00 (ref) 1.00 (ref) 
 ≤ 1 cup/day 203 420 0.48 (0.34-0.68) 0.69 (0.45-1.07) 
 >1 to 2 cups/day 224 412 0.54 (0.39-0.76) 0.60 (0.39-0.93) 
 >3 to 4 cups/day 280 295 0.94 (0.67-1.31) 0.86 (0.55-1.33) 
 >4 cups/day 181 110 1.61 (1.10-2.35) 1.06 (0.65-1.72) 
Duration of consumption5     
 Never3 89 88 1.00 (ref) 1.00 (ref) 
 < 20 years 44 68 0.53 (0.32 - 0.87) 0.71 (0.38-1.30) 
 ≥ 20 to < 30 years 99 134 0.57 (0.38 - 0.87) 0.88 (0.51-1.50) 
 ≥ 30 to < 40 years 223 310 0.64 (0.45 - 0.91) 0.68 (0.43-1.07) 
 ≥ 40 to < 50 years 347 455 0.82 (0.59 - 1.14) 0.76 (0.49-1.17) 
 ≥ 50 years 175 271 0.78 (0.54 - 1.13) 0.73 (0.45-1.18) 
Cumulative consumption5     
 Never3 89 88 1.00 (ref) 1.00 (ref) 
 ≤ 40 years, ≤ 2 cups/day 150 318 0.42 (0.29-0.60) 0.60 (0.38-0.94) 
 ≤ 40 years, > 2 cups/day 217 197 0.95 (0.66-1.38 0.87 (0.54-1.38) 
 > 40 years, ≤ 2 cups/day 277 515 0.59 (0.42-0.82) 0.68 (0.44-1.05) 
 > 40 years, > 2 cups/day 244 208 1.27 (0.89-1.81) 0.97 (0.61-1.53) 
1. Only includes participants with complete information on their coffee consumption 
2. Adjusted for age, sex, respondent status, smoking (CSI), wine intake (never; weekly, not daily; daily), ethnicity (French Canadian; English 
Canadian; other), median census tract income (low; medium; high), years of education (<7; 7-<12; ≥12) and occupational exposure to 
carcinogens (Never; non-substantial; substantial) 
3. Participants were categorized as never consumers if they reported never consuming coffee at least once per week  
4: Participants were categorized as “weekly, not daily” consumers if they reported consuming coffee at least once per week but not nearly every 
day 
5. “Weekly, not daily” consumers not included 
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Table IV. Odds ratio estimates of the association between black tea and coffee consumption and lung cancer risk by histological subtype1 
Black tea consumption metric3 
OR (95%CI)2 


















Frequency of consumption    Frequency of consumption    
 Never5 1.00 (ref) 1.00 (ref) 1.00 (ref)  Never5 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Weekly, not daily6 0.81 (0.51–1.29) 0.84 (0.57–1.25) 0.78 (0.42–1.43)  Weekly, not daily6 0.32 (0.13–0.83) 0.50 (0.22 – 1.10) 0.10 (0.02–0.50) 
 Daily 1.07 (0.78–1.48) 1.13 (0.85–1.51) 0.85 (0.55–1.30)  Daily 0.83 (0.46–1.49) 0.93 (0.54 – 1.59) 0.65 (0.32–1.33) 
        
Average daily amount of consumption7    Average daily amount of consumption7    
 Never5 1.00 (ref) 1.00 (ref) 1.00 (ref)  Never5 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 1 cup/day 0.78 (0.49-1.23) 0.99 (0.67-1.48) 0.82 (0.46-1.49)  ≤ 1 cup/day 0.72 (0.38-1.38) 0.82 (0.46-1.48) 0.64 (0.29-1.42) 
 >1 to 2 cups/day 1.15 (0.75-1.76) 1.15 (0.78-1.68) 0.60 (0.32-1.12)  >1 to 2 cups/day 0.70 (0.37-1.33) 0.75 (0.42-1.35) 0.46 (0.21-1.04) 
 >2 cups/day 1.48 (0.93-2.34) 1.39 (0.90-2.15) 1.32 (0.70-2.48)  >2 to 4 cups/day 0.95 (0.50-1.80) 1.24 (0.69-2.21) 0.68 (0.31-1.49) 
     >4 cups/day 1.25 (0.62-2.52) 1.15 (0.60-2.18) 1.05 (0.45-2.45) 
        
Duration of consumption7    Duration of consumption7    
 Never5 1.00 (ref) 1.00 (ref) 1.00 (ref)  Never5 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 < 30 years 1.27 (0.73–2.21) 1.15 (0.71–1.85) 1.13 (0.55–2.30)  < 30 years 0.80 (0.37-1.71) 1.14 (0.60-2.19) 0.50 (0.19-1.30) 
 ≥ 30 to < 40 years 1.22 (0.69–2.14) 1.12 (0.68–1.85) 0.74 (0.33–1.68)  ≥ 30 to < 40 years 0.91 (0.46-1.77) 0.90 (0.50-1.64) 0.59 (0.26-1.34) 
 ≥ 40 to < 50 years 0.98 (0.64–1.52) 0.89 (0.58–1.36) 0.70 (0.38–1.29)  ≥ 40 to < 50 years 0.88 (0.47-1.65) 0.88 (0.49-1.58) 0.71 (0.33-1.54) 
 ≥ 50 years 1.01 (0.60–1.68) 1.60 (1.01–2.52) 0.92 (0.45-1.91)  ≥ 50 years 0.68 (0.34-1.36) 0.91 (0.48-1.75) 0.73 (0.30-1.80) 
        
Cumulative consumption7    Cumulative consumption7    
 Never5 1.00 (ref) 1.00 (ref) 1.00 (ref)  Never5 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 40 years, ≤ 2 cups/day 0.99 (0.61-1.60) 1.01 (0.67-1.54) 0.80 (0.42-1.52)  ≤ 40 years, ≤ 2 cups/day 0.74 (0.37-1.48) 0.73 (0.39-1.35) 0.51 (0.21-1.21) 
 ≤ 40 years, > 2 cups/day 2.18 (1.07-4.46) 1.61 (0.83-3.15) 1.55 (0.55-4.38)  ≤ 40 years, > 2 cups/day 0.97 (0.48-1.94) 1.34 (0.72-2.49) 0.62 (0.27-1.44) 
 > 40 years, ≤ 2 cups/day 0.93 (0.61-1.43) 1.11 (0.76-1.64) 0.64 (0.35-1.17)  > 40 years, ≤ 2 cups/day 0.69 (0.37-1.30) 0.84 (0.47-1.53) 0.57 (0.26-1.27) 
 > 40 years, > 2 cups/day 1.20 (0.70-2.08) 1.28 (0.75-2.17) 1.22 (0.59-2.56)  > 40 years, > 2 cups/day 1.09 (0.56-2.11) 1.15 (0.62-2.15) 0.99 (0.44-2.23) 
1. n=322 cases of squamous cell carcinoma, 438 cases of adenocarcinoma and 183 cases of small cell carcinoma 
2. Adjusted for age, sex, respondent status, smoking (CSI), wine intake (never; weekly, not daily; daily), ethnicity (French Canadian; English Canadian; other), median census tract income (low; 
medium; high), years of education (<7; 7-<12; ≥12) and occupational exposure to carcinogens (Never; non-substantial; substantial) 
/drug effects/physiology</keyword><keyword>Signal Transduction/*drug effects/physiology4. Only includes participants with complete information on their coffee consumption 
4. Only includes participants with complete information on their coffee consumption 
5. Participants were categorized as never consumers if they reported never consuming black tea/coffee at least once per week  
6: Participants were categorized as “weekly, not daily” consumers if they reported consuming black tea/coffee at least once per week but not nearly every day 





Appendix table A.I. Odds ratio estimates for the association between black tea consumption and 
lung cancer risk, by sex and by smoking level1 
Consumption metric 
OR (95% CI) by sex2 OR (95% CI) by smoking level3 
Males    Females   Never/light smokers  Heavy smokers  
Frequency of consumption     
 Never4   1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Weekly, not daily5 0.88 (0.60–1.31) 0.66 (0.40–1.09) 0.79 (0.53–1.19) 0.82 (0.51–1.32) 
 Daily 1.10 (0.84–1.45) 0.98 (0.67–1.44) 1.08 (0.80–1.46) 1.02 (0.74–1.41) 
pinteraction6 0.41 0.84 
     
Average daily amount7     
 Never4   1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 1 cup/day 0.84 (0.57-1.24) 1.21 (0.72-2.01) 1.12 (0.75-1.68) 0.76 (0.48-1.20) 
 >1 to 2 cups/day 1.26 (0.87-1.83) 0.78 (0.47-1.30) 0.97 (0.64-1.45) 1.14 (0.73-1.79) 
 >2 cups/day 1.37 (0.90-2.09) 1.09 (0.61-1.94) 1.34 (0.83-2.14) 1.20 (0.74-1.94) 
pinteraction6 0.29 0.47 
     
Duration of consumption7     
 Never4   1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 < 30 years 1.25 (0.74–2.12) 1.27 (0.71–2.25) 1.18 (0.73–1.93) 1.26 (0.68–2.33) 
 ≥ 30 to < 40 years 1.31 (0.77–2.20) 0.67 (0.36–1.23) 0.70 (0.39–1.27) 1.27 (0.70–2.31) 
 ≥ 40 to < 50 years 0.92 (0.63–1.34) 0.93 (0.52–1.65) 1.12 (0.73–1.72) 0.75 (0.48–1.18) 
 ≥ 50 years 1.24 (0.80–1.91) 1.26 (0.65–2.44) 1.41 (0.87–2.27) 1.08 (0.63–1.86) 
pinteraction6 0.47 0.13 
     
Cumulative consumption7     
 Never4   1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 40 years, ≤ 2 cups/day 1.05 (0.67-1.64) 0.91 (0.55-1.50) 0.87 (0.56-1.37) 1.07 (0.65-1.77) 
 ≤ 40 years, > 2 cups/day 1.98 (0.98-3.98) 1.12 (0.49-2.54) 1.14 (0.56-2.33) 2.32 (0.92-5.89) 
 > 40 years, ≤ 2 cups/day 1.03 (0.72-1.46) 1.05 (0.61-1.82) 1.20 (0.80-1.78) 0.85 (0.55-1.31) 
 > 40 years, > 2 cups/day 1.14 (0.69-1.88) 1.10 (0.53-2.26) 1.51 (0.85-2.68) 0.91 (0.52-1.58) 
pinteraction6 0.69 0.11 
1. Only includes participants with complete information on their black tea consumption 
2. Adjusted for age, respondent status, smoking (CSI), wine intake (never; weekly, not daily; daily), ethnicity (French Canadian; English 
Canadian; other), median census tract income (low; medium; high), years of education (<7; 7-<12; ≥12) and occupational exposure to 
carcinogens (Never; non-substantial; substantial) 
3. Adjusted for same covariates as above, plus sex 
4. Participants were categorized as never consumers if they reported never consuming black tea at least once per week  
5: Participants were categorized as “weekly, not daily” consumers if they reported consuming black tea at least once per week but not nearly 
every day 
6. pinteraction is the p-value for the test of for interaction between the consumption metric and either sex or smoking level 
7. “Weekly, not daily” consumers not included 
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Appendix table A.II. Odds ratio estimates for the association between coffee consumption and lung 
cancer risk, by sex and by smoking level1 
Consumption metric 
OR (95% CI) by sex2 OR (95% CI) by smoking level3 
Males       Females  Never/light 
smokers  
Heavy smokers  
Frequency of consumption     
 Never4 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Weekly, not daily5 0.22 (0.10–0.47) 0.58 (0.20–1.70) 0.24 (0.10–0.58) 0.32 (0.12–0.85) 
 Daily 0.68 (0.41 – 1.12) 0.87 (0.44–1.73) 0.63 (0.38–1.04) 0.80 (0.41–1.57) 
pinteraction6 0.27 0.80 
     
Average daily amount7     
 Never4 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 1 cup/day 0.68 (0.40-1.16) 0.75 (0.36-1.58) 0.55 (0.32-0.96) 0.86 (0.41-1.79) 
 >1 to 2 cups/day 0.56 (0.33-0.96) 0.70 (0.34-1.47) 0.51 (0.29-0.88) 0.66 (0.32-1.35) 
 >2 to 4 cups/day 0.74 (0.43-1.27) 1.23 (0.58-2.58) 0.76 (0.43-1.33) 0.91 (0.45-1.85) 
 >4 cups/day 0.92 (0.50-1.68) 1.33 (0.58-3.05) 1.19 (0.63-2.27) 0.86 (0.40-1.84) 
pinteraction6 0.73 0.45 
     
Duration of consumption7     
 Never4 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 < 30 years 0.60 (0.31-1.17) 1.37 (0.61-3.08) 0.75 (0.41-1.38) 0.83 (0.35-1.99) 
 ≥ 30 to < 40 years 0.57 (0.32-1.00) 0.95 (0.45-2.04) 0.53 (0.29-0.95) 0.72 (0.34-1.50) 
 ≥ 40 to < 50 years 0.74 (0.44-1.26) 0.77 (0.36-1.63) 0.60 (0.35-1.04) 0.90 (0.44-1.81) 
 ≥ 50 years 0.76 (0.42-1.36) 0.64 (0.27-1.50) 0.67 (0.36-1.24) 0.79 (0.37-1.70) 
pinteraction6 0.99 0.35 
     
Cumulative consumption7     
 Never4 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 ≤ 40 years, ≤ 2 cups/day 0.51 (0.28-0.92) 0.84 (0.40-1.80) 0.47 (0.27-0.85) 0.74 (0.34-1.60) 
 ≤ 40 years, > 2 cups/day 0.66 (0.36-1.19) 1.45 (0.66-3.18) 0.83 (0.45-1.53) 0.74 (0.34-1.59) 
 > 40 years, ≤ 2 cups/day 0.69 (0.41-1.17) 0.61 (0.29-1.32) 0.57 (0.33-1.00) 0.76 (0.37-1.55) 
 > 40 years, > 2 cups/day 0.91 (0.52-1.59) 1.10 (0.49-2.44) 0.90 (0.49-1.64) 1.01 (0.49-2.10) 
pinteraction6 0.78 0.34 
1. Only includes participants with complete information on their coffee consumption 
2. Adjusted for age, respondent status, smoking (CSI), wine intake (never; weekly, not daily; daily), ethnicity (French Canadian; English 
Canadian; other), median census tract income (low; medium; high), years of education (<7; 7-<12; ≥12) and occupational exposure to 
carcinogens (Never; non-substantial; substantial) 
3. Adjusted for same covariates as above, plus sex 
4. Participants were categorized as never consumers if they reported never consuming coffee at least once per week  
5: Participants were categorized as “weekly, not daily” consumers if they reported consuming coffee at least once per week but not nearly every 
day 
6. pinteraction is the p-value for the test of for interaction between the consumption metric and either sex or smoking level 
7. “Weekly, not daily” consumers not included 
 
